跳至主要内容

Western Immunoblot Assay Test

 A western blot is a method in molecular biology/biochemistry/immunogenetics to detect protein in a given sample of tissue homogenate or extract. It uses gel electrophoresis to separate denatured proteins by mass. The proteins are then transferred out of the gel and onto a membrane, where they are “probed” using antibodies specific to the protein. As a result, researchers can examine the amount of protein in a given sample and compare levels between several groups.

western blot service

The Biology Department of Medicilon has extensive experience in the field of in vitro biology, through enzyme level determination, cell level determination, cell biology, biochemistry, in vitro isotope determination, stable cell line establishment, gene knockout, RNAi and MicroRNA Technology, etc., provide a complete set of biological services.

Western Blot Related Antibodies

Secondary Antibody

Tag Antibody

Loading Control Antibody

Isotype Control Antibody

Techniques:

Immunological Detection of Antigens

Handling of Antibody and Antibody-Enzyme Conjugate Reagents

Reagent Preparation

General Immunoblotting Protocol

Immunoblotting is typically used to determine the amount (dot blot) and molecular weight (western blot) of an antigen present in a complex mixture. The highly sensitive procedure below is suggested. All incubations are at room temperature.

This procedure is for nitrocellulose or PVDF membranes. Do not touch the membrane! Wear gloves. PVDF membranes must be pre-wet with 100% methanol before equilibrating in transfer buffer. Nylon membranes may be used, however, they are more difficult to block. To block nylon membranes use buffer without Tween-20, replace BSA with 10% nonfat dry milk and block for several hours to overnight at 4 degrees C. When selecting membranes, the specifications of the particular imaging systems with their available filters must be taken into consideration. Some membranes may exhibit auto fluorescence at certain wavelengths.

Western Blot Procedure

Western blots allow investigators to determine the molecular weight of a protein and to measure relative amounts of the protein present in different samples.

  1. 1. Transfer and immobilize antigen on nitrocellulose or PVDF membrane.
  2. 2. Block by immersing the membrane in TTBS. Use just enough solution to cover the membrane. Never let the membrane become dry during the procedure. Incubate for 30 minutes with gentle agitation. The addition of 1.0% BSA to the blocking solution increases signal-to-noise ration over the use of TTBS aloe. Some antigens and antibodies may be eluted in the presence of Tween-20. If this occurs, replace the Tween-20 with 1.0% BSA in all TTBS solutions and repeat the experiment.
  3. 3. Transfer the membrane to diluted solution of primary antibody in TTBS. The appropriate dilution should be determined by trial and error. Serial ten fold dilutions starting at 1:10 are suggested. Incubate for 30 minutes with gentle agitation.
  4. 4. Wash with 3 changes of TTBS for 5 minutes each with gentle agitation.
  5. 5. Transfer the membrane to a dilute solution of biotinylated secondary antibody in TTBS. Confirm reagent specificity for primary antibody. Incubate for 30 minutes with gentle agitation.
  6. 6. Repeat step 4.
  7. 7. Transfer the membrane to a solution of peroxidase conjugated streptavidin appropriately diluted in TTBS. Incubate at 30 minutes with gentle agitation.
  8. 8. During the above incubation, prepare the enzyme substrate. Use DAB for a dark brown color or TMB for a bright blue color.
  9. 9. Wash as in step 3.
  10. 10. Transfer the membrane to the substrate solution. Incubate until color develops sufficiently (usually 2-20 minutes).
  11. 11. Wash with 2 changes of water for 5 minutes each with gentle agitation. Allow membrane to dry and store in the dark.

Western Blot or immunoblot is a workhorse immunoassay for most labs, used to demonstrate the presence or absence of important proteins, detect post-translational modifications, diagnosis of disease and more. Not all antibodies work well in a western blot assay, due to the fact that the protein is denatured and the epitope (antibody binding site) of the protein of interest may not be accessible. Specific screening may be required to detect antibodies that are compatible with western blotting and optimization of the assay conditions to maximize their performance.

Contact Us 

Email : marketing@medicilon.com

Tel : +44 1223 981 792 (Europe)

+82 (0)70-8269-5849 (South Korea)

08044216898 (Japan)

+86 021 58591500 (China)

Website: https://www.medicilon.com

Tips : Above is part of Western Immunoblot, Western Blot Analysis and Western Blot Assay Test. You can also CONTACT US with any question or enquiry you may have. We will be happy to discuss your needs in detail and design an appropriate plan of action.

Related Articles:

western blot assay

Single Cell Western Blot

Western Blot Analysis Services

标签：

评论

发表评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou
发表评论
阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d
发表评论
阅读全文

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati
发表评论
阅读全文